Lentiviral Vector Mediated Haematopoietic Stem Cell Gene Therapy for the Treatment of Lysosomal Disease

被引:0
|
作者
McDermott, J. H. [1 ]
Langford-Smith, A. [1 ]
Sergijenko, A. [1 ]
Langford-Smith, K. J. [1 ]
Liao, A. [1 ]
Jones, S. A. [2 ]
Wraith, J. E. [2 ]
Wynn, R. F. [3 ]
Wilkinson, F. W. [1 ]
Bigger, B. W. [1 ]
机构
[1] Univ Manchester, Manchester, Lancs, England
[2] St Marys Hosp, Manchester M13 0JH, Lancs, England
[3] RMCH, Blood & Marrow Transplant Unit, Manchester, Lancs, England
来源
JOURNAL OF PATHOLOGY | 2013年 / 231卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [1] Immunological and metabolic correction after lentiviral vector mediated haematopoietic stem cell gene therapy for ADA deficiency
    Gaspar, Bobby
    Buckland, Karen
    Rivat, Christine
    Himoudi, Nourredine
    Gilmour, Kimberly
    Booth, Claire
    Xu-Bayford, Jinhua
    Cornetta, Kenneth
    Kohn, Donald
    Carbonaro, Denise
    Paruzynski, Anna
    Schmidt, Manfred
    Thrasher, Adrian
    HUMAN GENE THERAPY, 2014, 25 (05) : A4 - A5
  • [2] Immunological and Metabolic Correction After Lentiviral Vector Mediated Haematopoietic Stem Cell Gene Therapy for ADA Deficiency
    Gaspar, Hubert B.
    Buckland, Karen
    Rivat, Christine
    Himoudi, Nourredine
    Gilmour, Kimberly
    Booth, Claire
    Cornetta, Kenneth
    Kohn, Donald B.
    Carbonaro, Denise
    Paruzynski, Anna
    Schmidt, Manfred
    Thrasher, Adrian J.
    MOLECULAR THERAPY, 2014, 22 : S106 - S106
  • [3] Immunological and Metabolic Correction After Lentiviral Vector Mediated Haematopoietic Stem Cell Gene Therapy for ADA Deficiency
    Gaspar, B.
    Buckland, K.
    Rivat, C.
    Booth, C.
    Gilmour, K.
    Cornetta, K.
    Carbonaro, D.
    Schmidt, M.
    Kohn, D. B.
    Thrasher, A. J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S167 - S168
  • [4] Immunological and metabolic correction after lentiviral vector mediated haematopoietic stem cell gene therapy for ADA deficiency
    Gaspar, Hubert B.
    Buckland, Karen
    Rivat, Christine
    Himoudi, Nourredine
    Gilmour, Kimberly
    Booth, Claire
    Cornetta, Kenneth
    Kohn, Don B.
    Carbonaro, Denise
    Paruzynski, Anna
    Schmidt, Manfred
    Thrasher, Adrian J.
    HUMAN GENE THERAPY, 2014, 25 (11) : A6 - A6
  • [5] Lentiviral vector enhanced haematopoietic stem cell gene therapy for mucopolysaccharidosis type IIIA
    Langford-Smith, A.
    Wilkinson, F.
    Langford-Smith, K. J.
    Sergijenko, A.
    Bennett, W.
    Howe, S.
    Thrasher, A.
    Jones, S.
    Wraith, J. E.
    Wynn, R.
    Bigger, B.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S316 - S316
  • [6] Haematopoietic stem cell gene therapy and inflammation in CNS lysosomal diseases
    Bigger, B.
    HUMAN GENE THERAPY, 2019, 30 (08) : A5 - A6
  • [7] Lentiviral vector-mediated stem cell gene therapy for mucopolysaccharidosis type IIIA (MPSIIIA)
    Langford-Smith, Alex
    Wilkinson, Fiona
    Bennett, William
    Hopwood, John
    Wraith, Ed
    Wynn, Rob
    Bigger, Brian
    HUMAN GENE THERAPY, 2009, 20 (11) : 1396 - 1397
  • [8] Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy
    Montini, Eugenio
    Naldini, Luigi
    Booth, Claire
    Kohn, Donald B.
    Aiuti, Alessandro
    MOLECULAR THERAPY, 2025, 33 (01) : 6 - 8
  • [9] Lentiviral Haematopoietic Stem Cell Gene Therapy for Late Juvenile Metachromatic Leukodystrophy
    Calbi, Valeria
    Gallo, Vera
    De Mattia, Fabiola
    Zambon, Alberto
    Recupero, Salvatore
    Fratini, Elena Sophia
    Clerici, Alessandra
    Morena, Francesco
    Martino, Sabata
    Brooks, Jean
    Richardson, Alan
    Cambpell, Laura
    Bernardo, Maria Ester
    Aiuti, Alessandro
    Fumagalli, Francesca
    MOLECULAR THERAPY, 2024, 32 (04) : 887 - 887
  • [10] Lentiviral Vector-Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA (MPSIIIA)
    Langford-Smith, A. W. W.
    Wilkinson, F. L.
    Langford-Smith, K. J.
    Bennett, W.
    Howe, S.
    Thrasher, A.
    Hemsley, K.
    Hopwood, J.
    Wraith, J. E.
    Wynn, R. F.
    Bigger, B. W.
    HUMAN GENE THERAPY, 2010, 21 (04) : 502 - 503